240 related articles for article (PubMed ID: 12667409)
1. The relationship between MTHFR gene polymorphisms, plasma homocysteine levels and diabetic retinopathy in type 2 diabetes mellitus.
Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
Chin Med J (Engl); 2003 Jan; 116(1):145-7. PubMed ID: 12667409
[TBL] [Abstract][Full Text] [Related]
2. [The relationship of methylenetetrahydrofolate reductase gene polymorphism and plasma homocysteine levels in type 2 diabetes mellitus patients with diabetic retinopathy].
Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):131-4. PubMed ID: 12673582
[TBL] [Abstract][Full Text] [Related]
3. [The association of methylenetetrahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus in Chinese].
Sun J; Xu Y; Zhu Y
Zhonghua Nei Ke Za Zhi; 2001 Aug; 40(8):529-32. PubMed ID: 11718053
[TBL] [Abstract][Full Text] [Related]
4. Plasma homocysteine and microvascular complications in type 1 diabetes.
Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
[TBL] [Abstract][Full Text] [Related]
5. Thermolabile methylenetetrahydrofolate reductase enzyme genotype is frequent in type 2 diabetic patients with normal fasting homocysteine levels.
Tutuncu NB; Erbas T; Alikasifoglu M; Tuncbilek E
J Intern Med; 2005 May; 257(5):446-53. PubMed ID: 15836661
[TBL] [Abstract][Full Text] [Related]
6. [The abnormal reaction to post methionine loading test in type diabetes with or without retinopathy].
Guo Q; Lu J; Pan C
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):725-8. PubMed ID: 12126538
[TBL] [Abstract][Full Text] [Related]
7. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
[TBL] [Abstract][Full Text] [Related]
8. Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
Soares AL; Fernandes AP; Cardoso JE; Sousa MO; Lasmar MC; Novelli BA; Lages GF; Dusse LM; Vieira LM; Lwaleed BA; Carvalho MG
Pathophysiol Haemost Thromb; 2008; 36(5):275-81. PubMed ID: 19996639
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine, folate, methylene tetrahydrofolate reductase genotype and vascular morbidity in diabetic subjects.
Kaye JM; Stanton KG; McCann VJ; Vasikaran SD; Burke V; Taylor RR; van Bockxmeer FM
Clin Sci (Lond); 2002 Jun; 102(6):631-7. PubMed ID: 12049616
[TBL] [Abstract][Full Text] [Related]
10. [Levels of homocysteine and polymorphisms of homocysteine metabolism-related enzymes in patients with type 2 diabetes mellitus and coronary heart disease].
Luo D; Yan S; Cheng X; Song Y
Wei Sheng Yan Jiu; 2009 Jan; 38(1):39-42. PubMed ID: 19267073
[TBL] [Abstract][Full Text] [Related]
11. Total plasma homocysteine is associated with hypertension in Type I diabetic patients.
Neugebauer S; Tarnow L; Stehouwer C; Teerlink T; Baba T; Watanabe T; Parving HH
Diabetologia; 2002 Sep; 45(9):1315-24. PubMed ID: 12242465
[TBL] [Abstract][Full Text] [Related]
12. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
Hermans MP; Gala JL; Buysschaert M
Diabet Med; 2006 May; 23(5):529-36. PubMed ID: 16681562
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase polymorphism, type II diabetes mellitus, coronary artery disease, and essential hypertension in the Czech population.
Benes P; Kanková K; Muzík J; Groch L; Benedík J; Elbl L; Izakovicová-Hollá L; Vasků A; Znojil V; Vácha J
Mol Genet Metab; 2001 Jun; 73(2):188-95. PubMed ID: 11386855
[TBL] [Abstract][Full Text] [Related]
14. Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.
Huh HJ; Chi HS; Shim EH; Jang S; Park CJ
Thromb Res; 2006; 117(5):501-6. PubMed ID: 15935452
[TBL] [Abstract][Full Text] [Related]
15. The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients.
Fukasawa M; Matsushita K; Kamiyama M; Mikami Y; Araki I; Yamagata Z; Takeda M
Am J Kidney Dis; 2003 Mar; 41(3):637-42. PubMed ID: 12612987
[TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease; evidence that all three MTHFR C677T genotypes confer different levels of risk.
Kluijtmans LA; Whitehead AS
Eur Heart J; 2001 Feb; 22(4):294-9. PubMed ID: 11161947
[TBL] [Abstract][Full Text] [Related]
17. [Genetic polymorphisms of homocysteine metabolism related enzymes in patients with coronary heart disease].
Xu H; Chen Z; Tang J
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):414-6. PubMed ID: 11715433
[TBL] [Abstract][Full Text] [Related]
18. Methylenetetrahydrofolate reductase gene polymorphism, homocysteine and risk of macroangiopathy in Type 2 diabetes mellitus.
Sun J; Xu Y; Zhu Y; Lu H
J Endocrinol Invest; 2006 Oct; 29(9):814-20. PubMed ID: 17114913
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in IDDM patients.
Shcherbak NS; Shutskaya ZV; Sheidina AM; Larionova VI; Schwartz EI
Mol Genet Metab; 1999 Nov; 68(3):375-8. PubMed ID: 10562465
[TBL] [Abstract][Full Text] [Related]
20. [The relationship between the mutation of methylenetetrahydrofolate reductase gene 677C-->T and the diabetic microangiopathy].
Hu S; Gan P; Li J; Bi H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):118-21. PubMed ID: 11295130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]